IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma

Clinical trial NCT06412458 · UNKNOWN

Trial details

NCT number: NCT06412458
Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Osteosarcoma Recurrent Osteosarcoma

Start date: 2024-06-15
Primary completion: 2025-06-15
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.